Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPalpha (CCAAT/enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP321751.RAtiANIbUWFm9KZlK7n9oQx0SMk0jk38RvMrBY8G4-_qU130_assertion description "[Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPalpha (CCAAT/enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321751.RAtiANIbUWFm9KZlK7n9oQx0SMk0jk38RvMrBY8G4-_qU130_provenance.
• NP804827.RAfwM0NXcpPepCixAH4AqQb3fG5Yv2hFR_XId9_AISJE4130_assertion description "[Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPalpha (CCAAT/enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804827.RAfwM0NXcpPepCixAH4AqQb3fG5Yv2hFR_XId9_AISJE4130_provenance.
• NP427226.RAHs2oO8H3f-CP75wgqEgoTL5GAYc0s-U_SjHeCrJFTcc130_assertion description "[Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPalpha (CCAAT/enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427226.RAHs2oO8H3f-CP75wgqEgoTL5GAYc0s-U_SjHeCrJFTcc130_provenance.
• NP427174.RAXFDxqbH5ro7AORm4LOgoRDq3gAjgfCPX3lOSYdoEd1I130_assertion description "[Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPalpha (CCAAT/enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427174.RAXFDxqbH5ro7AORm4LOgoRDq3gAjgfCPX3lOSYdoEd1I130_provenance.
• NP427176.RAZ1YiProSn3PnyQHtzRtVAuzncS0fMsPgHH3jvsJiCag130_assertion description "[Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPalpha (CCAAT/enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427176.RAZ1YiProSn3PnyQHtzRtVAuzncS0fMsPgHH3jvsJiCag130_provenance.
• NP427177.RAUNgdhC7Vwoh_hyY7Vdi8pk9H353Kzy0vGhMNedJF2hk130_assertion description "[Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPalpha (CCAAT/enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427177.RAUNgdhC7Vwoh_hyY7Vdi8pk9H353Kzy0vGhMNedJF2hk130_provenance.
• NP711006.RArynGyxR5dPJQMXv2sry-vInLiZLHkqwLtk9a39j_68o130_assertion description "[Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPalpha (CCAAT/enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711006.RArynGyxR5dPJQMXv2sry-vInLiZLHkqwLtk9a39j_68o130_provenance.
• NP976257.RAMb9oIhiyNiZwlB0VotlF8is_A69dA5CecKg0slB64sg130_assertion description "[Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPalpha (CCAAT/enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP976257.RAMb9oIhiyNiZwlB0VotlF8is_A69dA5CecKg0slB64sg130_provenance.
• NP851486.RAOBWBpUMZFtOwnztRhQFJMtDlkoEUnqZbAsHDdIBNYec130_assertion description "[Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPalpha (CCAAT/enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851486.RAOBWBpUMZFtOwnztRhQFJMtDlkoEUnqZbAsHDdIBNYec130_provenance.
• NP427171.RApps6ojgpTZWpIASgRssB0hlAwmCwnDMSxl3cF0pA_hE130_assertion description "[Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPalpha (CCAAT/enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427171.RApps6ojgpTZWpIASgRssB0hlAwmCwnDMSxl3cF0pA_hE130_provenance.
• NP427173.RAgdCy1pjChKRoBiu40_9Xycxh-UHnpdJC3wDigDKRa3s130_assertion description "[Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPalpha (CCAAT/enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427173.RAgdCy1pjChKRoBiu40_9Xycxh-UHnpdJC3wDigDKRa3s130_provenance.